Physician profile
Nidal Isber
NPI 1043272776
$4,425.04
in general payments reported to CMS, 2019-2025
22 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $567 · 2021: $796 · 2022: $747 · 2023: $625 · 2024: $453 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $854.69 | 2019-2025 | Lifevest |
| Pfizer INC. | $554.37 | 2019-2022 | |
| Medtronic, INC. | $441.31 | 2021-2025 | Linq II, Onyx Frontier, Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $343.90 | 2019-2023 | |
| Medtronic Vascular, INC. | $286.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $231.53 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $227.99 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $220.33 | 2019-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $170.51 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $163.20 | 2019 | |
| Kestra Medical Technology Services, INC. | $156.82 | 2023-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $147.66 | 2020-2023 | Farxiga |
| Inari Medical, INC. | $146.60 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $107.38 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $93.37 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $89.02 | 2024 | Arcalyst |
| Catheter Precision INC. | $50.61 | 2023 | |
| Scpharmaceuticals INC. | $35.74 | 2024-2025 | |
| Abiomed | $33.10 | 2023 | Impella |
| Shockwave Medical, INC | $31.97 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $24.79 | 2023 | Inpefa |
| Chiesi USA, INC. | $14.03 | 2023 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidal Isber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.